Silverarc Capital Management, LLC has filed its 13F form on November 12, 2025 for Q3 2025 where it was disclosed a total value porftolio of $486 Million distributed in 82 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Rhythm Pharmaceuticals, Inc. with a value of $37.4M, Avidity Biosciences, Inc. with a value of $36.8M, Nuvalent, Inc. with a value of $32.2M, Uro Gen Pharma Ltd. with a value of $30.8M, and Akero Therapeutics, Inc. with a value of $30.6M.
Examining the 13F form we can see an increase of $72.1M in the current position value, from $414M to 486M.
Below you can find more details about Silverarc Capital Management, LLC portfolio as well as his latest detailed transactions.
